Safiyyah Ahmed, Abrar Ansari, Md Aminul Islam +1cs.CL cs.AI
The growing use of large language models (LLMs) for search and information retrieval underscores the need to evaluate their reliability in high-stakes domains such as healthcare. Although LLMs can effectively answer questions about diseases, symptoms, and treatments, their ability to accurately assess causal relationships and ground their conclusions in verified scientific evidence remains unclear. Here, we present a preliminary, small-scale study that investigates the accuracy of LLMs in evaluating causal medical claims and supporting them with peer-reviewed research. We propose an evaluation framework for causal hypothesis verification that can be used to systematically track the performance of existing and future LLMs. We assess the performance of eight LLMs on 17 medical causal hypotheses to evaluate whether they can reliably verify these hypotheses using scientific evidence from the literature. We systematically annotate the scientific evidence they provide according to six criteria (a total of 1,067 annotation points) and assess them with nine evaluation metrics. Our analysis shows that while LLMs exhibit strong recall, they often perform poorly at providing valid scientific articles and evidence for support and at rejecting unsupported hypotheses. These findings highlight a critical limitation of current LLMs, as they cannot yet be trusted fully to verify causal relationships from the biomedical literature. This work underscores the need for rigorous evaluation before using LLMs for search and retrieval in healthcare settings.
Evidence derived from large-scale real-world data (RWD) is increasingly informing regulatory evaluation and healthcare decision-making. Administrative claims provide population-scale, longitudinal records of healthcare utilization, expenditure, and detailed coding of diagnoses, procedures, and medications, yet their potential as a substrate for healthcare foundation models remains largely unexplored. Here we present ReClaim, a generative transformer trained from scratch on 43.8 billion medical events from more than 200 million enrollees in the MarketScan claims data spanning 2008-2022. ReClaim models longitudinal trajectories across diagnoses, procedures, medications, and expenditure, and was scaled to 140 million, 700 million, and 1.7 billion parameters. Across over 1,000 disease-onset prediction tasks, ReClaim achieved a mean AUC of 75.6%, substantially outperforming disease-specific LightGBM (66.3%) and the transformer-based Delphi model (69.4%), with the largest gains for rare diseases. These advantages held across retrospective and prospective evaluations and in external validation on two independent datasets. Performance improved monotonically with scale, and post-training added 13.8 percentage points over pre-training alone. Beyond disease prediction, ReClaim captured financial outcomes and improved real-world evidence (RWE) analyses: for healthcare expenditure forecasting it increased explained variance from 0.28 to 0.37 relative to LightGBM, and in a target trial emulation it reduced systematic bias by 72% on average relative to Delphi. Together, these results establish administrative claims as a scalable substrate for healthcare foundation models and show that learned representations generalize across time periods and data sources, supporting disease surveillance, expenditure forecasting, and RWE generation.